NuVasive, Inc. NASDAQ: NUVA



An estimated 10 million U.S. adults suffer from chronic back pain each year and most have problems with degenerative and related conditions. NuVasive can help.

We develop minimally disruptive, procedurally-integrated solutions for spine and beyond.

Our mission is to improve the lives of patients who suffer from
debilitating back, neck, or leg pain by creating cutting-edge
products and procedures that revolutionize spine surgery.

NuVasive launched the NuVasive Spine Foundation™ (NSF) in 2009 with a mission to provide medical equipment, surgical support, and necessary funds to those in need of life-saving spine surgery around the world. The NSF leads medical mission trips and provides aid to those who suffer from chronic back and leg pain, which embodies our commitment to an ‘Attitude of Gratitude’.

The NuVasive approach to Minimally Invasive Surgery (MIS) is a new surgical platform called Maximum Access Surgery (MAS®), because it delivers the benefit of traditional surgery and the reduced trauma of MIS. By comparison, traditional “open” spine surgery often requires an incision that is at least 4-6 inches, whereas MAS technology typically requires an incision that is just a couple of inches.

At NuVasive, we are best known for developing the XLIF® procedure, a minimally disruptive procedure that allows spine surgeons to have direct access to the intervertebral disc space (the “joint” of the spine) from the side of the body, as opposed to the front or back. The XLIF procedure is just one of many innovative NuVasive procedures which have redefined spine surgery and beyond.